Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
Daniel A. Ladin, Eman Soliman, LaToya M. Griffin, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report
Donald I. Abrams
European Journal of Internal Medicine (2018) Vol. 49, pp. 7-11
Closed Access | Times Cited: 260
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
Kinga Tóth, Dorottya Ádám, Tamás Bı́ró, et al.
Molecules (2019) Vol. 24, Iss. 5, pp. 918-918
Open Access | Times Cited: 176
Cannabinoids: Therapeutic Use in Clinical Practice
Cristina Pagano, Giovanna Navarra, Laura Coppola, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3344-3344
Open Access | Times Cited: 145
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
Attila Oláh, Zoltán Szekanecz, Tamás Bı́ró
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 118
Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia
Miguel Olivas-Aguirre, Liliana Torres-López, Salvador Valle‐Reyes, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 10
Open Access | Times Cited: 114
Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back
Osnat Almogi‐Hazan, Reuven Or
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4448-4448
Open Access | Times Cited: 100
Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs
Claudia A. Dumitru, I. Erol Sandalcioglu, Meliha Karsak
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 90
Cannabinoids in the landscape of cancer
Nagina Mangal, Simon Erridge, Nagy Habib, et al.
Journal of Cancer Research and Clinical Oncology (2021) Vol. 147, Iss. 9, pp. 2507-2534
Open Access | Times Cited: 82
Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities
Samridhi Lal, Anusmita Shekher, Puneet Kumar, et al.
Pharmacological Research (2020) Vol. 163, pp. 105302-105302
Closed Access | Times Cited: 75
Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma
Tamara T. Lah, Metka Novak, Milagros A. Pena Almidon, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 340-340
Open Access | Times Cited: 71
Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview
Pradeep Kumar, Dipendra Kumar Mahato, Madhu Kamle, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 11, pp. 6010-6029
Closed Access | Times Cited: 71
Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care
Donald I. Abrams
Integrative Cancer Therapies (2022) Vol. 21
Open Access | Times Cited: 39
Cannabidiol - a friend or a foe?
Bianca-Maria Tihăuan, Tatiana Onisei, Walter Slootweg, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107036-107036
Open Access | Times Cited: 1
Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration
Katherine A. Scott, Angus Dalgleish, Wai M. Liu
International Journal of Oncology (2017) Vol. 51, Iss. 1, pp. 369-377
Open Access | Times Cited: 79
Cannabis Use, Lung Cancer, and Related Issues
James R. Jett, Emily Stone, Graham Warren, et al.
Journal of Thoracic Oncology (2018) Vol. 13, Iss. 4, pp. 480-487
Open Access | Times Cited: 65
Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer
Andrea M. Tomko, Lauren O’Leary, Hilary Trask, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 48
Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer
Golnaz Sharafi, Hong He, Mehrdad Nikfarjam
Journal of Pancreatic Cancer (2019) Vol. 5, Iss. 1, pp. 1-7
Open Access | Times Cited: 46
Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol
Miguel Olivas-Aguirre, Liliana Torres-López, Igor Pottosin, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 40
Natural bioactive molecules: An alternative approach to the treatment and control of glioblastoma multiforme
Priti Tagde, Pooja Tagde, Sandeep Tagde, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111928-111928
Open Access | Times Cited: 40
Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms
Ken Soderstrom, Eman Soliman, Rukiyah Van Dross
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 40
The Immune Endocannabinoid System of the Tumor Microenvironment
Melanie Kienzl, Julia Kargl, Rudolf Schicho
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 8929-8929
Open Access | Times Cited: 37
Cannabis as an Anticancer Agent: A Review of Clinical Data and Assessment of Case Reports
Jordan Guggisberg, Megan L. Schumacher, Grace Gilmore, et al.
Cannabis and Cannabinoid Research (2021) Vol. 7, Iss. 1, pp. 24-33
Open Access | Times Cited: 29
ACPA decreases non-small cell lung cancer line growth through Akt/PI3K and JNK pathways in vitro
Özge Boyacıoğlu, Elif Bilgiç, Cem Varan, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Antitumor Cannabinoid Chemotypes: Structural Insights
Paula Morales, Nadine Jagerovic
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 31
Synergistic cytotoxic activity of cannabinoids fromcannabis sativaagainst cutaneous T-cell lymphoma (CTCL)in-vitroandex-vivo
Moran Mazuz, Amir Tiroler, Lilach Moyal, et al.
Oncotarget (2020) Vol. 11, Iss. 13, pp. 1141-1156
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top